CLDX
Price
$25.86
Change
+$0.57 (+2.25%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
1.72B
34 days until earnings call
FDMT
Price
$8.68
Change
-$0.05 (-0.57%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
407.71M
34 days until earnings call
Interact to see
Advertisement

CLDX vs FDMT

Header iconCLDX vs FDMT Comparison
Open Charts CLDX vs FDMTBanner chart's image
Celldex Therapeutics
Price$25.86
Change+$0.57 (+2.25%)
Volume$16.22K
Capitalization1.72B
4D Molecular Therapeutics
Price$8.68
Change-$0.05 (-0.57%)
Volume$4.63K
Capitalization407.71M
CLDX vs FDMT Comparison Chart in %
Loading...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLDX vs. FDMT commentary
Oct 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDX is a Hold and FDMT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 03, 2025
Stock price -- (CLDX: $25.29 vs. FDMT: $8.73)
Brand notoriety: CLDX and FDMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDX: 83% vs. FDMT: 41%
Market capitalization -- CLDX: $1.72B vs. FDMT: $407.71M
CLDX [@Biotechnology] is valued at $1.72B. FDMT’s [@Biotechnology] market capitalization is $407.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $104.83B to $0. The average market capitalization across the [@Biotechnology] industry is $1.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDX’s FA Score shows that 0 FA rating(s) are green whileFDMT’s FA Score has 0 green FA rating(s).

  • CLDX’s FA Score: 0 green, 5 red.
  • FDMT’s FA Score: 0 green, 5 red.
According to our system of comparison, CLDX is a better buy in the long-term than FDMT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDX’s TA Score shows that 7 TA indicator(s) are bullish while FDMT’s TA Score has 4 bullish TA indicator(s).

  • CLDX’s TA Score: 7 bullish, 3 bearish.
  • FDMT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CLDX is a better buy in the short-term than FDMT.

Price Growth

CLDX (@Biotechnology) experienced а -1.21% price change this week, while FDMT (@Biotechnology) price change was +3.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.18%. For the same industry, the average monthly price growth was +13.86%, and the average quarterly price growth was +79.28%.

Reported Earning Dates

CLDX is expected to report earnings on Nov 05, 2025.

FDMT is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+5.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLDX($1.72B) has a higher market cap than FDMT($408M). FDMT YTD gains are higher at: 56.732 vs. CLDX (0.079). FDMT has higher annual earnings (EBITDA): -213.2M vs. CLDX (-231.4M). CLDX has more cash in the bank: 630M vs. FDMT (293M). CLDX has less debt than FDMT: CLDX (3.03M) vs FDMT (23.1M). CLDX has higher revenues than FDMT: CLDX (5.79M) vs FDMT (33K).
CLDXFDMTCLDX / FDMT
Capitalization1.72B408M421%
EBITDA-231.4M-213.2M109%
Gain YTD0.07956.7320%
P/E RatioN/AN/A-
Revenue5.79M33K17,545%
Total Cash630M293M215%
Total Debt3.03M23.1M13%
FUNDAMENTALS RATINGS
CLDX: Fundamental Ratings
CLDX
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
74
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLDXFDMT
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TISPX73.57N/A
N/A
Nuveen S&P 500 Index R6
FGNCX12.90N/A
N/A
Nuveen Global Infrastructure C
ABYEX9.95N/A
N/A
AB Emerging Markets Multi-Asset Advisor
TRMVX28.69N/A
N/A
SEI Large Cap Value F (SIMT)
ANODX24.65N/A
N/A
American Century Small Cap Growth R6

FDMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, FDMT has been loosely correlated with LRMR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if FDMT jumps, then LRMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FDMT
1D Price
Change %
FDMT100%
+0.46%
LRMR - FDMT
43%
Loosely correlated
+28.48%
RGNX - FDMT
42%
Loosely correlated
+1.24%
ARCT - FDMT
41%
Loosely correlated
+11.12%
IDYA - FDMT
40%
Loosely correlated
+0.55%
CLDX - FDMT
40%
Loosely correlated
-2.24%
More